Found: 107
Select item for more details and to access through your institution.
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 10, p. 1337, doi. 10.15252/emmm.201505357
- By:
- Publication type:
- Article
A white man with a very African form of hereditary amyloid cardiomyopathy.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Clinical ApoA‐IV amyloid is associated with fibrillogenic signal sequence.
- Published in:
- Journal of Pathology, 2021, v. 255, n. 3, p. 311, doi. 10.1002/path.5770
- By:
- Publication type:
- Article
Renal transplant outcomes in amyloidosis.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 2, p. 355, doi. 10.1093/ndt/gfaa293
- By:
- Publication type:
- Article
Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27416-z
- By:
- Publication type:
- Article
The transthyretin amyloidoses: advances in therapy.
- Published in:
- Postgraduate Medical Journal, 2015, v. 91, n. 1078, p. 439, doi. 10.1136/postgradmedj-2014-133224
- By:
- Publication type:
- Article
Response rates to second‐line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib‐based regime.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 138, doi. 10.1111/bjh.19529
- By:
- Publication type:
- Article
Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. 422, doi. 10.1111/bjh.18645
- By:
- Publication type:
- Article
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 328, doi. 10.1111/bjh.18216
- By:
- Publication type:
- Article
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real‐world longitudinal data.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 587, doi. 10.1111/bjh.17636
- By:
- Publication type:
- Article
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 643, doi. 10.1111/bjh.16401
- By:
- Publication type:
- Article
A 24‐year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 642, doi. 10.1111/bjh.16143
- By:
- Publication type:
- Article
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 638, doi. 10.1111/bjh.16122
- By:
- Publication type:
- Article
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. 460, doi. 10.1111/bjh.15955
- By:
- Publication type:
- Article
Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 977, doi. 10.1111/bjh.15675
- By:
- Publication type:
- Article
Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 145, doi. 10.1111/bjh.14747
- By:
- Publication type:
- Article
Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 4, p. 575, doi. 10.1111/bjh.14908
- By:
- Publication type:
- Article
Guidelines on the management of AL amyloidosis.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 2, p. 186, doi. 10.1111/bjh.13155
- By:
- Publication type:
- Article
Guidelines on the diagnosis and investigation of AL amyloidosis.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 2, p. 207, doi. 10.1111/bjh.13156
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 6, p. 842, doi. 10.1111/bjh.12973
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 842, doi. 10.1111/bjh.12973
- By:
- Publication type:
- Article
Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosis.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 6, p. 856, doi. 10.1111/bjh.12433
- By:
- Publication type:
- Article
Long‐term outcomes in light chain deposition disease‐analysis of a UK cohort.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E444, doi. 10.1002/ajh.26725
- By:
- Publication type:
- Article
A specific nanobody prevents amyloidogenesis of D76N β<sub>2</sub>-microglobulin in vitro and modifies its tissue distribution in vivo.
- Published in:
- Scientific Reports, 2017, p. 46711, doi. 10.1038/srep46711
- By:
- Publication type:
- Article
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 4, p. 333, doi. 10.1093/eurheartj/ehab507
- By:
- Publication type:
- Article
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.
- Published in:
- European Heart Journal, 2021, v. 42, n. 16, p. 1554, doi. 10.1093/eurheartj/ehab072
- By:
- Publication type:
- Article
UK National Amyloidosis Centre: The National Amyloidosis Centre at the Royal Free Hospital and University College London is the world's largest amyloidosis centre with almost 1500 patient referrals annually.
- Published in:
- European Heart Journal, 2019, v. 40, n. 21, p. 1661, doi. 10.1093/eurheartj/ehz346
- By:
- Publication type:
- Article
Extracellular volume with bolus-only technique in amyloidosis patients: Diagnostic accuracy, correlation with other clinical cardiac measures, and ability to track changes in amyloid load over time.
- Published in:
- 2018
- By:
- Publication type:
- journal article
British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis.
- Published in:
- Echo Research & Practice, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s44156-023-00028-7
- By:
- Publication type:
- Article
Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.
- Published in:
- Clinical Autonomic Research, 2024, v. 34, n. 3, p. 341, doi. 10.1007/s10286-024-01038-z
- By:
- Publication type:
- Article
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 537, doi. 10.1111/ejh.13582
- By:
- Publication type:
- Article
The value of screening biopsies in light‐chain (AL) and transthyretin (ATTR) amyloidosis.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 352, doi. 10.1111/ejh.13458
- By:
- Publication type:
- Article
Comparison of Free Light Chain Assays: Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of Free Light Chain Assays.
- Published in:
- American Journal of Clinical Pathology, 2016, v. 146, n. 1, p. 78, doi. 10.1093/AJCP/AQW079
- By:
- Publication type:
- Article
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
- Published in:
- BMC Family Practice, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s12875-020-01252-4
- By:
- Publication type:
- Article
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.
- Published in:
- Nature, 2010, v. 468, n. 7320, p. 93, doi. 10.1038/nature09494
- By:
- Publication type:
- Article
Peripheral neuropathy secondary to a 'domino' liver transplant: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature.
- Published in:
- Arthritis Research & Therapy, 2013, v. 15, n. 1, p. 1, doi. 10.1186/ar4171
- By:
- Publication type:
- Article
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network.
- Published in:
- Clinical Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1016/j.clinme.2023.100004
- By:
- Publication type:
- Article
Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy.
- Published in:
- Heart International, 2023, v. 17, n. 1, p. 27, doi. 10.17925/HI.2023.17.1.27
- By:
- Publication type:
- Article
Imaging-Guided Treatment for Cardiac Amyloidosis.
- Published in:
- Current Cardiology Reports, 2022, v. 24, n. 7, p. 839, doi. 10.1007/s11886-022-01703-7
- By:
- Publication type:
- Article
Transthyretin cardiac amyloidosis.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 18, p. 3517, doi. 10.1093/cvr/cvac119
- By:
- Publication type:
- Article
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin‐mediated amyloidosis with polyneuropathy.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 397, doi. 10.1002/ejhf.3138
- By:
- Publication type:
- Article
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 65, doi. 10.1002/ejhf.3094
- By:
- Publication type:
- Article
Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 515, doi. 10.1002/ejhf.2776
- By:
- Publication type:
- Article
Systemic embolism in amyloid transthyretin cardiomyopathy.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 8, p. 1387, doi. 10.1002/ejhf.2566
- By:
- Publication type:
- Article
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 512, doi. 10.1002/ejhf.2140
- By:
- Publication type:
- Article
Comparison of different technetium-99m-labelled bone tracers for imaging cardiac amyloidosis.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 3, p. e4, doi. 10.1093/eurjpc/zwac237
- By:
- Publication type:
- Article
Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue--a case series and genetic exploration.
- Published in:
- Rheumatology, 2017, v. 56, n. 2, p. 209, doi. 10.1093/rheumatology/kew058
- By:
- Publication type:
- Article
Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 422, p. 1, doi. 10.1126/scitranslmed.aan3128
- By:
- Publication type:
- Article